Barely Significant
← all excerpts

CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma.

Front Immunol · 2025 · PMC12745396 · PMID 41472741

2
hedged sentences
0.2300
closest p · 4.6× alpha
0.2900
boldest claim

The sentences

showed a trendp = 0.23not close (p > 0.1)
Consistent with our previous findings ( Figure 3A ), additional validation analyses showed a trend toward eosinophil enrichment ( p = 0.23) and CD4 memory activated ( p < 0.01) in the ABC subtype, and a significant enrichment of M0 macrophages in the GCB subtype ( Supplementary Figure 5A ).

also in 53,322 other papers

did not reach statistical significancep = 0.29not close (p > 0.1)
Consistently, high MAPK10 levels were also associated with shorter progression-free survival (PFS) in the overall cohort ( p = 0.028; Figure 5C ), although this trend did not reach statistical significance when restricted to ABC cases ( p = 0.29; Figure 5D ) or GCB cases ( Supplementary Figure 4D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.